Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J van Dalen

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
British Heart Journal|May 1, 1988
Cost benefit analysis of early thrombolytic treatment with intracoronary streptokinase. Twelve month follow up report of the randomised multicentre trial conducted by the Interuniversity Cardiology Institute of The NetherlandsF Vermeer, M L Simoons, C de Zwaan, et al.
Nature Biotechnology|June 29, 2002
In situ delivery of passive immunity by lactobacilli producing single-chain antibodiesCarina Krüger, Yanzhong Hu, Qiang Pan, et al.
The Journal of Prevention of Alzheimer'S Disease|January 31, 2022
The Effect of Multidomain Interventions on Global Cognition, Symptoms of Depression and Apathy - A Pooled Analysis of Two Randomized Controlled TrialsM G H E den Brok, M P Hoevenaar-Blom, N Coley, et al.
Molecular & Cellular Proteomics : MCP|August 11, 2025
Proteome and secretome profiling of the melanoma-induced transition towards immune incompetent dendritic cells reveals enhanced IDO1, cathepsin, and legumain activityAnouk M D Becker, Bob J Ignacio, Jelmer J Dijkstra, et al.
Contemporary Clinical Trials|May 19, 2007
Diagnostic criteria and adjudication process both determine published event-rates: the ACTION trial experienceBridget-Anne Kirwan, Jacobus Lubsen, Sophie de Brouwer, et al.
Annals of the Rheumatic Diseases|April 12, 2012
Increased type II deiodinase protein in OA-affected cartilage and allelic imbalance of OA risk polymorphism rs225014 at DIO2 in human OA joint tissuesSteffan D Bos, Judith V M G Bovée, Bouke J Duijnisveld, et al.
Bioconjugate Chemistry|January 21, 2021
Dual Site-Specific Chemoenzymatic Antibody Fragment Conjugation Using CRISPR-Based Hybridoma EngineeringCamille M Le Gall, Johan M S van der Schoot, Iván Ramos-Tomillero, et al.
Nature Chemical Biology|May 29, 2024
Antibody-peptide conjugates deliver covalent inhibitors blocking oncogenic cathepsinsAaron Petruzzella, Marine Bruand, Albert Santamaria-Martínez, et al.
BMC Psychiatry|January 17, 2019
Group schema-focused therapy enriched with psychomotor therapy versus treatment as usual for older adults with cluster B and/or C personality disorders: a randomized trialS D M van Dijk, M S Veenstra, R Bouman, et al.
RSC Chemical Biology|May 9, 2025
Co-delivery of antigen and adjuvant by site-specific conjugation to dendritic cell-targeted Fab fragments potentiates T cell responsesZacharias Wijfjes, Iván Ramos Tomillero, Camille M Le Gall, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
British Heart Journal|May 1, 1988
Cost benefit analysis of early thrombolytic treatment with intracoronary streptokinase. Twelve month follow up report of the randomised multicentre trial conducted by the Interuniversity Cardiology Institute of The NetherlandsF Vermeer, M L Simoons, C de Zwaan, et al.
Nature Biotechnology|June 29, 2002
In situ delivery of passive immunity by lactobacilli producing single-chain antibodiesCarina Krüger, Yanzhong Hu, Qiang Pan, et al.
The Journal of Prevention of Alzheimer'S Disease|January 31, 2022
The Effect of Multidomain Interventions on Global Cognition, Symptoms of Depression and Apathy - A Pooled Analysis of Two Randomized Controlled TrialsM G H E den Brok, M P Hoevenaar-Blom, N Coley, et al.
Molecular & Cellular Proteomics : MCP|August 11, 2025
Proteome and secretome profiling of the melanoma-induced transition towards immune incompetent dendritic cells reveals enhanced IDO1, cathepsin, and legumain activityAnouk M D Becker, Bob J Ignacio, Jelmer J Dijkstra, et al.
Contemporary Clinical Trials|May 19, 2007
Diagnostic criteria and adjudication process both determine published event-rates: the ACTION trial experienceBridget-Anne Kirwan, Jacobus Lubsen, Sophie de Brouwer, et al.
Annals of the Rheumatic Diseases|April 12, 2012
Increased type II deiodinase protein in OA-affected cartilage and allelic imbalance of OA risk polymorphism rs225014 at DIO2 in human OA joint tissuesSteffan D Bos, Judith V M G Bovée, Bouke J Duijnisveld, et al.
Bioconjugate Chemistry|January 21, 2021
Dual Site-Specific Chemoenzymatic Antibody Fragment Conjugation Using CRISPR-Based Hybridoma EngineeringCamille M Le Gall, Johan M S van der Schoot, Iván Ramos-Tomillero, et al.
Nature Chemical Biology|May 29, 2024
Antibody-peptide conjugates deliver covalent inhibitors blocking oncogenic cathepsinsAaron Petruzzella, Marine Bruand, Albert Santamaria-Martínez, et al.
BMC Psychiatry|January 17, 2019
Group schema-focused therapy enriched with psychomotor therapy versus treatment as usual for older adults with cluster B and/or C personality disorders: a randomized trialS D M van Dijk, M S Veenstra, R Bouman, et al.
RSC Chemical Biology|May 9, 2025
Co-delivery of antigen and adjuvant by site-specific conjugation to dendritic cell-targeted Fab fragments potentiates T cell responsesZacharias Wijfjes, Iván Ramos Tomillero, Camille M Le Gall, et al.
Pageof 8